Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial

INTRODUCTION: Shorter duration of treatment for the management of drug-susceptible pulmonary tuberculosis (TB) would be a significant improvement in the care of patients suffering from the disease. Besides newer drugs and regimens, other modalities like host-directed therapy are also being suggested...

Descripción completa

Detalles Bibliográficos
Autores principales: Padmapriyadarsini, Chandrasekaran, Bhavani, Perumal K, Natrajan, Mohan, Ponnuraja, Chinnayan, Kumar, Hemanth, Gomathy, Sivaramakrishnan N, Guleria, Randeep, Jawahar, Shaheed M, Singh, Manjula, Balganesh, Tanjore, Swaminathan, Soumya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429929/
https://www.ncbi.nlm.nih.gov/pubmed/30826761
http://dx.doi.org/10.1136/bmjopen-2018-024363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429929/
https://www.ncbi.nlm.nih.gov/pubmed/30826761
http://dx.doi.org/10.1136/bmjopen-2018-024363

Ejemplares similares